Marcatili M

Department of Mental Health, Fondazione IRCSS San Gerardo dei Tintori, Monza, Italy.

8 papers

ArticleKetamine

Pilot study on esketamine response in treatment-resistant depression: impact of pharmacogenetic, clinical, and demographic variables.

Krivosova M, Marcatili M, Guerrera G +8

Europe PMC2026
ArticleKetamine

Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.

Olivola M, Mazzoni F, Tarantino B +12

Europe PMC2025
ArticleKetamine

Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study.

Olivola M, Mazzoni F, Tarantino B +11

Europe PMC2026
ArticleKetamine

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Di Nicola M, Pepe M, d'Andrea G +26

Europe PMC2025
ArticleKetamine

Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group.

Rosso G, d'Andrea G, Barlati S +15

Europe PMC2025
ArticleKetamine

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.

d'Andrea G, Pettorruso M, Di Lorenzo G +16

Europe PMC2024
ArticleKetamine

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).

Pettorruso M, Guidotti R, d'Andrea G +25

Europe PMC2023
ArticleKetamine

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Martinotti G, Dell'Osso B, Di Lorenzo G +23

Europe PMC2023